| ■ 영문 제목 : Global RNAi for Therapeutic Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02293 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 100 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 치료용 RNAi의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (siRNA, miRNA, shRNA)와 용도별 시장규모 (암, 심혈관, HBV, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 치료용 RNAi 시장 점유율 - 지역별 치료용 RNAi 시장규모 - 주요지역의 종류별 시장규모 (siRNA, miRNA, shRNA) - 주요지역의 용도별 시장규모 (암, 심혈관, HBV, 기타) - 미주의 치료용 RNAi 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 치료용 RNAi 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 치료용 RNAi 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 치료용 RNAi 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 치료용 RNAi 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, Quark Pharmaceuticals, RXi Pharmaceuticals, Silence Therapeutics, Benitec Biopharma, miRagen Therapeutics, Sylentis, Gradalis, Sirnaomics, Silenseed - 조사의 결과/결론 |
According to this latest study, the 2021 growth of RNAi for Therapeutic will have significant change from previous year. By the most conservative estimates of global RNAi for Therapeutic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 128.2 million in 2020. Over the next five years the RNAi for Therapeutic market will register a 44.7% CAGR in terms of revenue, the global market size will reach US$ 562 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of RNAi for Therapeutic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
siRNA
miRNA
shRNA
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Cancer
Cardiovascular
HBV
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
1 Scope of the Report 2 Executive Summary 3 RNAi for Therapeutic Market Size by Players 4 RNAi for Therapeutic by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global RNAi for Therapeutic Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. RNAi for Therapeutic Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of siRNA Table 3. Major Players of miRNA Table 4. Major Players of shRNA Table 5. RNAi for Therapeutic Market Size CAGR by Type (2020-2026) & ($ Millions) Table 6. Global RNAi for Therapeutic Market Size by Type (2016-2021) & ($ Millions) Table 7. Global RNAi for Therapeutic Market Size Market Share by Type (2016-2021) Table 8. RNAi for Therapeutic Market Size CAGR by Application (2016-2021) & ($ Millions) Table 9. Global RNAi for Therapeutic Market Size by Application (2016-2021) & ($ Millions) Table 10. Global RNAi for Therapeutic Market Size Market Share by Application (2016-2021) Table 11. Global RNAi for Therapeutic Revenue by Players (2019-2021E) & ($ Millions) Table 12. Global RNAi for Therapeutic Revenue Market Share by Players (2019-2021E) Table 13. RNAi for Therapeutic Key Players Head office and Products Offered Table 14. RNAi for Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global RNAi for Therapeutic Market Size by Regions 2016-2021 & ($ Millions) Table 18. Global RNAi for Therapeutic Market Size Market Share by Regions 2016-2021 Table 19. Americas RNAi for Therapeutic Market Size by Country (2016-2021) & ($ Millions) Table 20. Americas RNAi for Therapeutic Market Size Market Share by Country (2016-2021) Table 21. Americas RNAi for Therapeutic Market Size by Type (2016-2021) & ($ Millions) Table 22. Americas RNAi for Therapeutic Market Size Market Share by Type (2016-2021) Table 23. Americas RNAi for Therapeutic Market Size by Application (2016-2021) & ($ Millions) Table 24. Americas RNAi for Therapeutic Market Size Market Share by Application (2016-2021) Table 25. APAC RNAi for Therapeutic Market Size by Region (2016-2021) & ($ Millions) Table 26. APAC RNAi for Therapeutic Market Size Market Share by Region (2016-2021) Table 27. APAC RNAi for Therapeutic Market Size by Type (2016-2021) & ($ Millions) Table 28. APAC RNAi for Therapeutic Market Size Market Share by Type (2016-2021) Table 29. APAC RNAi for Therapeutic Market Size by Application (2016-2021) & ($ Millions) Table 30. APAC RNAi for Therapeutic Market Size Market Share by Application (2016-2021) Table 31. Europe RNAi for Therapeutic Market Size by Country (2016-2021) & ($ Millions) Table 32. Europe RNAi for Therapeutic Market Size Market Share by Country (2016-2021) Table 33. Europe RNAi for Therapeutic Market Size by Type (2016-2021) & ($ Millions) Table 34. Europe RNAi for Therapeutic Market Size Market Share by Type (2016-2021) Table 35. Europe RNAi for Therapeutic Market Size by Application (2016-2021) & ($ Millions) Table 36. Europe RNAi for Therapeutic Market Size Market Share by Application (2016-2021) Table 37. Middle East & Africa RNAi for Therapeutic Market Size by Region (2016-2021) & ($ Millions) Table 38. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Region (2016-2021) Table 39. Middle East & Africa RNAi for Therapeutic Market Size by Type (2016-2021) & ($ Millions) Table 40. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Type (2016-2021) Table 41. Middle East & Africa RNAi for Therapeutic Market Size by Application (2016-2021) & ($ Millions) Table 42. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Application (2016-2021) Table 43. Key and Potential Regions of RNAi for Therapeutic Table 44. Key Application and Potential Industries of RNAi for Therapeutic Table 45. Key Challenges of RNAi for Therapeutic Table 46. Key Trends of RNAi for Therapeutic Table 47. Global RNAi for Therapeutic Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 48. Global RNAi for Therapeutic Market Size Market Share Forecast by Regions (2021-2026) Table 49. Global RNAi for Therapeutic Market Size Forecast by Type (2021-2026) & ($ Millions) Table 50. Global RNAi for Therapeutic Market Size Market Share Forecast by Type (2021-2026) Table 51. Global RNAi for Therapeutic Market Size Forecast by Application (2021-2026) & ($ Millions) Table 52. Global RNAi for Therapeutic Market Size Market Share Forecast by Application (2021-2026) Table 53. Alnylam Pharmaceuticals Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 54. Alnylam Pharmaceuticals RNAi for Therapeutic Product Offered Table 55. Alnylam Pharmaceuticals RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 56. Alnylam Pharmaceuticals Main Business Table 57. Alnylam Pharmaceuticals Latest Developments Table 58. Arbutus Biopharma (Tekmira) Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 59. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Offered Table 60. Arbutus Biopharma (Tekmira) Main Business Table 61. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 62. Arbutus Biopharma (Tekmira) Latest Developments Table 63. Arrowhead Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 64. Arrowhead RNAi for Therapeutic Product Offered Table 65. Arrowhead Main Business Table 66. Arrowhead RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 67. Arrowhead Latest Developments Table 68. Dicerna Pharmaceuticals Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 69. Dicerna Pharmaceuticals RNAi for Therapeutic Product Offered Table 70. Dicerna Pharmaceuticals Main Business Table 71. Dicerna Pharmaceuticals RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 72. Dicerna Pharmaceuticals Latest Developments Table 73. Mirna Therapeutics Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 74. Mirna Therapeutics RNAi for Therapeutic Product Offered Table 75. Mirna Therapeutics Main Business Table 76. Mirna Therapeutics RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 77. Mirna Therapeutics Latest Developments Table 78. Quark Pharmaceuticals Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 79. Quark Pharmaceuticals RNAi for Therapeutic Product Offered Table 80. Quark Pharmaceuticals Main Business Table 81. Quark Pharmaceuticals RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 82. Quark Pharmaceuticals Latest Developments Table 83. RXi Pharmaceuticals Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 84. RXi Pharmaceuticals RNAi for Therapeutic Product Offered Table 85. RXi Pharmaceuticals Main Business Table 86. RXi Pharmaceuticals RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 87. RXi Pharmaceuticals Latest Developments Table 88. Silence Therapeutics Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 89. Silence Therapeutics RNAi for Therapeutic Product Offered Table 90. Silence Therapeutics Main Business Table 91. Silence Therapeutics RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 92. Silence Therapeutics Latest Developments Table 93. Benitec Biopharma Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 94. Benitec Biopharma RNAi for Therapeutic Product Offered Table 95. Benitec Biopharma Main Business Table 96. Benitec Biopharma RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 97. Benitec Biopharma Latest Developments Table 98. miRagen Therapeutics Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 99. miRagen Therapeutics RNAi for Therapeutic Product Offered Table 100. miRagen Therapeutics Main Business Table 101. miRagen Therapeutics RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 102. miRagen Therapeutics Latest Developments Table 103. Sylentis Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 104. Sylentis RNAi for Therapeutic Product Offered Table 105. Sylentis RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 106. Sylentis Main Business Table 107. Sylentis Latest Developments Table 108. Gradalis Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 109. Gradalis RNAi for Therapeutic Product Offered Table 110. Gradalis Main Business Table 111. Gradalis RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 112. Gradalis Latest Developments Table 113. Sirnaomics Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 114. Sirnaomics RNAi for Therapeutic Product Offered Table 115. Sirnaomics Main Business Table 116. Sirnaomics RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 117. Sirnaomics Latest Developments Table 118. Silenseed Details, Company Type, RNAi for Therapeutic Area Served and Its Competitors Table 119. Silenseed RNAi for Therapeutic Product Offered Table 120. Silenseed Main Business Table 121. Silenseed RNAi for Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 122. Silenseed Latest Developments List of Figures Figure 1. RNAi for Therapeutic Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global RNAi for Therapeutic Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global RNAi for Therapeutic Market Size Market Share by Type in 2020 Figure 7. RNAi for Therapeutic in Cancer Figure 8. Global RNAi for Therapeutic Market: Cancer (2016-2021) & ($ Millions) Figure 9. RNAi for Therapeutic in Cardiovascular Figure 10. Global RNAi for Therapeutic Market: Cardiovascular (2016-2021) & ($ Millions) Figure 11. RNAi for Therapeutic in HBV Figure 12. Global RNAi for Therapeutic Market: HBV (2016-2021) & ($ Millions) Figure 13. RNAi for Therapeutic in Others Figure 14. Global RNAi for Therapeutic Market: Others (2016-2021) & ($ Millions) Figure 15. Global RNAi for Therapeutic Market Size Market Share by Application in 2020 Figure 16. Global RNAi for Therapeutic Revenue Market Share by Player in 2020 Figure 17. Global RNAi for Therapeutic Market Size Market Share by Regions (2016-2021) Figure 18. Americas RNAi for Therapeutic Market Size 2016-2021 ($ Millions) Figure 19. APAC RNAi for Therapeutic Market Size 2016-2021 ($ Millions) Figure 20. Europe RNAi for Therapeutic Market Size 2016-2021 ($ Millions) Figure 21. Middle East & Africa RNAi for Therapeutic Market Size 2016-2021 ($ Millions) Figure 22. Americas RNAi for Therapeutic Market Size Market Share by Country in 2020 Figure 23. Americas RNAi for Therapeutic Market Size Market Share by Type in 2020 Figure 24. Americas RNAi for Therapeutic Market Size Market Share by Application in 2020 Figure 25. United States RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 26. Canada RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 27. Mexico RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 28. APAC RNAi for Therapeutic Market Size Market Share by Regions in 2020 Figure 29. APAC RNAi for Therapeutic Market Size Market Share by Type in 2020 Figure 30. APAC RNAi for Therapeutic Market Size Market Share by Application in 2020 Figure 31. China RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 32. Japan RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 33. Korea RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 34. Southeast Asia RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 35. India RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 36. Australia RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 37. Europe RNAi for Therapeutic Market Size Market Share by Country in 2020 Figure 38. Europe RNAi for Therapeutic Market Size Market Share by Type in 2020 Figure 39. Europe RNAi for Therapeutic Market Size Market Share by Application in 2020 Figure 40. Germany RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 41. France RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 42. UK RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 43. Italy RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 44. Russia RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 45. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Region in 2020 Figure 46. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Type in 2020 Figure 47. Middle East & Africa RNAi for Therapeutic Market Size Market Share by Application in 2020 Figure 48. Egypt RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 49. South Africa RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 50. Israel RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 51. Turkey RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 52. GCC Country RNAi for Therapeutic Market Size Growth 2016-2021 ($ Millions) Figure 53. Americas RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 54. APAC RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 55. Europe RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 56. Middle East & Africa RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 57. United States RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 58. Canada RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 59. Mexico RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 60. Brazil RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 61. China RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 62. Japan RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 63. Korea RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 64. Southeast Asia RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 65. India RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 66. Australia RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 67. Germany RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 68. France RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 69. UK RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 70. Italy RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 71. Russia RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 72. Spain RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 73. Egypt RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 74. South Africa RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 75. Israel RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 76. Turkey RNAi for Therapeutic Market Size 2021-2026 ($ Millions) Figure 77. GCC Country RNAi for Therapeutic Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 치료용 RNAi 시장예측 2021년-2026년] (코드 : LPI-2201K02293) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 치료용 RNAi 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |